Anna Norhammar

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

Anna Norhammar, Åke Tenerz, Göran Nilsson et al. · The Lancet · 2002 · 1.1K citations

Metabolic Syndrome, Diabetes Management, Glucose Metabolism +9

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

Klas Malmberg, Anna Norhammar, Hans Wedel et al. · Circulation · 1999 · 852 citations

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu et al. · Circulation · 2017 · 791 citations · Full text

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

Kåre I. Birkeland, Marit E. Jørgensen, Bendix Carstensen et al. · The Lancet Diabetes & Endocrinology · 2017 · 363 citations

Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +12

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

Anna Norhammar, Klas Malmberg, Erik Diderholm et al. · Journal of the American College of Cardiology · 2004 · 329 citations

Ophthalmology, Cardiovascular Disease, Major Risk Factor +8